ELTEK VP discloses employee stock option holdings

ELTEK LTD executive Yitzhak Zemach, Vice President Operations, has reported his existing equity holdings on a Form 3.

Rhea-AI Filing Summary

ELTEK LTD executive Yitzhak Zemach, Vice President Operations, has reported his existing equity holdings on a Form 3. The filing lists five grants of employee stock options over a total of 42,500 underlying ordinary shares, with exercise prices ranging from $4.9400 to $15.8300 and expirations between 2031 and 2036. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and an additional 6.25% at the end of each following quarter.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Zemach Yitzhak

Role Vice President Operations

Type	Security	Shares	Price	Value
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--

Holdings After Transaction: Employee Stock Option — 42,500 contracts (Direct)

Footnotes (5)

1. F1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 24, 2021
2. F2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on August 3, 2023
3. F3. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 10, 2024
4. F4. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on January 1, 2026
5. F5. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 8, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ELTK executive Yitzhak Zemach report on this Form 3?

Yitzhak Zemach reports his existing holdings of ELTEK LTD employee stock options. The filing lists five option grants over 42,500 underlying ordinary shares, detailing exercise prices, expiration dates, and a four-year vesting schedule with quarterly vesting after the first anniversary.

How many ELTEK LTD shares underlie Yitzhak Zemach’s reported stock options?

The Form 3 shows options over 42,500 underlying ELTEK LTD ordinary shares. These are spread across five employee stock option grants, each with its own exercise price and expiration date, and follow a uniform four-year vesting pattern with quarterly vesting after the first year.

What are the exercise prices of Yitzhak Zemach’s ELTK employee stock options?

The reported employee stock options have exercise prices of $4.9400, $8.7000, $15.8300, $8.8400, and $8.8200. Each option corresponds to a separate grant over ELTEK LTD ordinary shares, with distinct expiration dates and a consistent four-year vesting schedule.

When do Yitzhak Zemach’s ELTEK LTD stock options expire?

The options expire on March 24, 2031, August 3, 2033, March 10, 2034, January 1, 2036, and March 8, 2036. Each date corresponds to a different employee stock option grant over ELTEK LTD ordinary shares reported on this Form 3.

How do the ELTK options reported by Yitzhak Zemach vest over time?

Each option grant vests over four years. Twenty-five percent of the options become exercisable on the first anniversary of the grant date, and an additional 6.25% become exercisable at the end of each subsequent quarter, until the full grant is vested over the four-year period.

Does this ELTK Form 3 show new stock transactions by Yitzhak Zemach?

The Form 3 records existing employee stock option positions, not new market trades. It lists five option grants, their exercise prices, expiration dates, and vesting terms, providing an overview of Zemach’s derivative equity holdings in ELTEK LTD as of the reporting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:48 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zemach Yitzhak

(Last) (First) (Middle)

2 WEIZMANN

(Street)

HOD HASHARON 4202553

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ELTEK LTD [ ELTK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President Operations

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option	(1)	03/24/2031	Ordinary share	7,500	$4.94	D
Employee Stock Option	(2)	08/03/2033	Ordinary share	8,000	$8.7	D
Employee Stock Option	(3)	03/10/2034	Ordinary share	10,000	$15.83	D
Employee Stock Option	(4)	01/01/2036	Ordinary share	10,000	$8.84	D
Employee Stock Option	(5)	03/08/2036	Ordinary share	7,000	$8.82	D

Explanation of Responses:

1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 24, 2021

2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on August 3, 2023

3. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 10, 2024

4. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on January 1, 2026

5. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 8, 2026

	/s/ Itzhak Zemach	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)